Search Results - Lingfeng Chen
- Showing 1 - 4 results of 4
-
1
Costunolide covalently targets NACHT domain of NLRP3 to inhibit inflammasome activation and alleviate NLRP3-driven inflammatory diseases by Haowen Xu, Jiahao Chen, Pan Chen, Weifeng Li, Jingjing Shao, Shanshan Hong, Yi Wang, Lingfeng Chen, Wu Luo, Guang Liang
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Compound 15c, a Novel Dual Inhibitor of EGFRL858R/T790M and FGFR1, Efficiently Overcomes Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Resistance of Non-Small-Cell Lun... by Gaozhi Chen, Gaozhi Chen, Yuyan Bao, Qiaoyou Weng, Yingxin Zhao, Xiaoyao Lu, Lili Fu, Lingfeng Chen, Zhiguo Liu, Xiaomin Zhang, Guang Liang
Published 2020Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
Identification of linderalactone as a natural inhibitor of SHP2 to ameliorate CCl4-induced liver fibrosis by Yi Zhang, Binhao Cai, Yingying Li, Ying Xu, Yuhan Wang, Lulu Zheng, Lulu Zheng, Xiaochun Zheng, Lina Yin, Gaozhi Chen, Yunxiang Wang, Guang Liang, Guang Liang, Lingfeng Chen
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
4
Doxofylline ameliorates liver fibrosis by regulating the ferroptosis signaling pathway by Lenan Xu, Lenan Xu, Meiling Zhang, Meiling Zhang, Junzhi Pan, Xiangwei Xu, Yawen Zhang, Xue Han, Lina Yin, Lingfeng Chen, Juan Ren, Jie Yu, Yanmei Zhang, Guang Liang, Guang Liang, Yi Zhang, Yi Zhang
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book